C World Wide Group Holding A Acadia Pharmaceuticals Inc Transaction History

C World Wide Group Holding A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$16.17 - $27.38 $128,438 - $217,479	-7,943 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$14.32 - $22.92 $2,921 - $4,675	-204 Reduced 2.5%	7,943 $128,000
Q3 2018 Nov 05, 2018	BUY	$13.03 - $21.81 $14,528 - $24,318	1,115 Added 15.86%	8,147 $169,000
Q1 2018 May 03, 2018	SELL	$22.47 - $32.33 $4,988 - $7,177	-222 Reduced 3.06%	7,032 $158,000
Q4 2017 Feb 07, 2018	SELL	$26.84 - $39.14 $27,027 - $39,413	-1,007 Reduced 12.19%	7,254 $218,000

Q3 2017 Nov 06, 2017	BUY	$29.49 - $38.37 $243,616 - $316,974	8,261	8,261 $311,000

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.